That includes more than $3 million dollars Baselga made when Roche bought Seragon, a startup that had paid him in stock. (Baselga's conflicts, though undisclosed in medical journals, were in that database.) This leads to deeper questions: How is it that a medical journal would allow a physician not to disclose a payment that exists in a public database? The obvious solution: have a public database that includes all those conflicts, and use it. The one created by the Sunshine Act is a start, and medical journals should check disclosure forms against it.

Source: Forbes September 10, 2018 18:30 UTC